美东时间2020年5月21日,ZNTL股价今开41.0500美元,盘中最高42.2700美元,盘中最低39.3914美元,股价收跌2.46%,跌1.0100点,报40.0600美元

ZNTL简介

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It use its highly efficient drug discovery engine, which it refer to as its Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believe could result in potentially differentiated product profiles. Its discovery engine combines its extensive experience and capabilities across cancer biology and medicinal chemistry.